Differential deposition of Manganese in the rat brain following subchronic exposure to manganese: A T1-weighted magnetic resonance imaging study

Israel Medical Association Journal

Volumn 10, Issue 11, 2008, Pages 793-798

  Finkelstein, Yoram ^a   Zhang, Na ^c   Fitsanakis, Vanessa A ^b   Avison, Malcolm J ^c   Gore, John C ^c,d   Aschner, Michael ^c,e  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

^b King College   (United Kingdom)

^c VANDERBILT UNIVERSITY   (United States)

^d VANDERBILT UNIVERSITY   (United States)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Magnetic resonance imaging; Manganese; Neurotoxicity; Rodent studies; Subchronic exposure

Indexed keywords

MANGANESE CHLORIDE; MANGANESE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; BRAIN TISSUE; CAUDATE NUCLEUS; CEREBELLUM; CHOROID PLEXUS; CONTROLLED STUDY; DENTATE GYRUS; ENVIRONMENTAL EXPOSURE; HABENULA; HIPPOCAMPUS; HYPOPHYSIS; IMAGE ANALYSIS; INTOXICATION; MALE; MANGANISM; MESENCEPHALON; NEUROTOXICITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OLFACTORY BULB; OPTIC CHIASM; OPTIC NERVE; PONS; RAT; TEGMENTUM; THALAMUS; TISSUE DISTRIBUTION; ANIMAL; BLOOD; BRAIN; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BRAIN; DENTATE GYRUS; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MALE; MANGANESE; MANGANESE POISONING; RATS; RATS, SPRAGUE-DAWLEY; TEGMENTUM MESENCEPHALI;

EID: 58149332711     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Finkelstein Y, Milatovic D, Aschner M. Modulation of cholinergic systems by manganese. Neurotoxicology 2007;28:1003-14.
2. Gorell JM, Johnson CC, Rybicki BA, et al. Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease. Neurotoxicology 1999;20:239-47.
3. Tanaka S. Manganese and its compounds. In: Zenz C, ed. Occupational Medicine. 32nd edn. St. Louis: Mosby Press, 1994: 213-17.
4. Reimund JM, Dietemann JL, Warter JM, Baumann R, Duclos B. Factors associated to hypermanganesemia in patients receiving home parenteral nutrition. Clin Nutr 2000;19:343-8.
5. Spahr L, Butterworth RF, Fontaine S, et al. Increased blood manganese in cirrhotic patients: relationship to pallidal magnetic resonance signal hyperintensity and neurological symptoms. Hepatology 1996;24:1116-20.
6. Stepens A, Logina I, Liguts V, et al. A Parkinsonian syndrome in methcathinone users and the role of manganese. N Engl J Med 2008;358:1009-17.
7. Gahlinger PM. Illegal Drugs. New York: Penguin Books, 2004: 231-7.
8. McMillan DE. A brief history of the neurobehavioral toxicity of manganese: some unanswered questions. Neurotoxicology 1999;20: 499-507.
9. Bleich S, Degner D, Sprung R, Riegel A, Poser W, Rüther E. Chronic manganism: fourteen years of follow-up. J Neuropsychiatry Clin Neurosci 1999;11:117.
10. Barbeau A, Inoué N, Cloutier T. Role of manganese in dystonia. Adv Neurol 1976;14:339-52.
11. Mergler D, Baldwin M. Early manifestations of manganese neurotoxicity in humans: an update. Environ Res 1997;73:92-100.
12. Fitsanakis VA, Zhang N, Avison MJ, Gore JC, Aschner JL, Aschner M. The use of magnetic resonance imaging (MRI) in the study of manganese neurotoxicity. Neurotoxicology 2006;27:798-806.
13. Kim Y. High signal intensities on T1-weighted MRI as a biomarker of exposure to manganese. Ind Health 2004;42:111-15.
14. Silva AC, Lee JH, Aoki I, Koretsky AP. Manganese-enhanced magnetic resonance imaging (MEMRI): methodological and practical considerations. NMR Biomed 2004;17:532-43.
15. Kang YS, Gore JC. Studies of tissue NMR relaxation enhancement by manganese. Dose and time dependences. Invest Radiol 1984;19:399-407.
16. Discalzi G, Pira E, Herrero Hernandez E, Valentini C, Turbiglio M, Meliga F. Occupational Mn parkinsonism: magnetic resonance imaging and clinical patterns following CaNa2-EDTA chelation. Neurotoxicology 2000;21:863-6.
17. London RE, Toney G, Gabel SA, Funk A. Magnetic resonance imaging studies of the brains of anesthetized rats treated with manganese chloride. Brain Res Bull 1989;23:229-35.
18. Lee JH, Silva AC, Merkle H, Koretsky AP. Manganese-enhanced magnetic resonance imaging of mouse brain after systemic administration of MnCl2: dose-dependent and temporal evolution of T1 contrast. Magn Reson Med 2005;53:640-8.
19. Chaki H, Furuta S, Matsuda A, et al. Magnetic resonance image and blood manganese concentration as indices for manganese content in the brain of rats. Biol Trace Elem Res 2000;74:245-57.
20. Fitsanakis VA, Zhang N, Anderson JG, Erikson KM, Avison MJ, Gore JC, Aschner M. Measuring brain manganese and iron accumulation in rats following 14 weeks of low-dose manganese treatment using atomic absorption spectroscopy and magnetic resonance imaging. Toxicol Sci 2008;103:116-24.
21. Gallez B, Baudelet C, Geurts M. Regional distribution of manganese found in the brain after injection of a single dose of manganese-based contrast agents. Magn Reson Imaging 1998;16: 1211-15.
22. Burdo JR, Menzies SL, Simpson IA, et al. Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat. J Neurosci Res 2001;66:1198-207.
23. Tandy S, Williams M, Leggett A, et al. Nramp2 expression is associated with pH-dependent iron uptake across the apical membrane of human intestinal Caco-2 cells. J Biol Chem 2000;275: 1023-9.
24. Gunshin H, Mackenzie B, Berger UV, et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 1997;388:482-8.
25. Vezér T, Kurunczi A, Náray M, Papp A, Nagymajtényi L. Behavioral effects of subchronic inorganic manganese exposure in rats. Am J Ind Med 2007;50:841-52.
26. Eyre MD, Richter-Levin G, Avital A, Stewart MG. Morphological changes in hippocampal dentate gyrus synapses following spatial learning in rats are transient. Eur J Neurosci 2003;17:1973-80.
27. Finkelstein Y, Koffler B, Rabey JM, Gilad GM. Dynamics of cholinergic synaptic mechanisms in rat hippocampus after stress. Brain Res 1985;343:314-19.
28. Mattsson A, Pernold K, Ogren SO, Olson L. Loss of cortical acetylcholine enhances amphetamine-induced locomotor activity. Neuroscience 2004;127:579-91.